ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 77 filers reported holding ADAGIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,270 | -17.3% | 3,100 | -48.9% | 0.00% | – |
Q2 2023 | $6,369 | -92.7% | 6,066 | -91.6% | 0.00% | – |
Q1 2023 | $87,057 | +19.4% | 72,548 | +49.2% | 0.00% | – |
Q4 2022 | $72,921 | +160.4% | 48,614 | +444.9% | 0.00% | – |
Q3 2022 | $28,000 | -71.1% | 8,921 | -69.8% | 0.00% | – |
Q2 2022 | $97,000 | -49.2% | 29,497 | -29.7% | 0.00% | – |
Q1 2022 | $191,000 | -89.4% | 41,979 | -83.1% | 0.00% | – |
Q4 2021 | $1,807,000 | +871.5% | 248,833 | +5569.5% | 0.00% | – |
Q3 2021 | $186,000 | – | 4,389 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 6,398,250 | $20,986,000 | 23.53% |
Foresite Capital Management V, LLC | 1,431,826 | $4,696,000 | 3.28% |
Alphabet Inc. | 5,680,785 | $18,633,000 | 1.01% |
683 Capital Management, LLC | 3,603,637 | $11,820,000 | 0.84% |
Slate Path Capital LP | 3,735,000 | $12,251,000 | 0.76% |
Bain Capital Life Sciences Investors, LLC | 1,937,207 | $6,354,000 | 0.74% |
Rubric Capital Management LP | 1,812,347 | $5,944,000 | 0.31% |
Orbimed Advisors | 5,056,000 | $16,584,000 | 0.30% |
Newtyn Management, LLC | 400,875 | $1,315,000 | 0.25% |
Redmile Group, LLC | 1,920,960 | $6,301,000 | 0.24% |